Transplant for Metabolic Disorders Syracuse NY

U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb. The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

Harcharan Singh
(315) 478-2339
1200 E Genesee St
Syracuse, NY
Specialty
Allergy / Immunology

Data Provided by:
Michael Sheehan
(315) 478-2339
1200 E Genesee St
Syracuse, NY
Specialty
Allergy / Immunology

Data Provided by:
Nicolae Andrei Popescu, MD
(315) 478-2339
1200 E Genesee St Ste 103
Syracuse, NY
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Inst De Med Si Farm, Carol Davila, Bucharest, Romania
Graduation Year: 1970

Data Provided by:
Thomas Raymond Adler, MD
(315) 452-2300
945 E Genesee St Ste 200
Syracuse, NY
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Of Ca, Irvine, Ca Coll Of Med, Irvine Ca 92717
Graduation Year: 1977

Data Provided by:
Edward Thomas Downing
(315) 475-8401
945 E Genesee St
Syracuse, NY
Specialty
Allergy / Immunology, Internal Medicine, Pulmonary Disease

Data Provided by:
Lawrence E Kurlandsky
(315) 464-7507
750 E Adams St
Syracuse, NY
Specialty
Allergy / Immunology

Data Provided by:
Michael Gerard Sheehan, MD
(315) 422-1070
1200 E Genesee St Ste 103
Syracuse, NY
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1984

Data Provided by:
Richard Kevin Sheehan, MD
(315) 478-2339
1200 E Genesee St
Syracuse, NY
Specialties
Pediatrics, Pediatric Allergy
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1958

Data Provided by:
Nicolae Andrei Popescu
(315) 478-2339
1200 E Genesee St
Syracuse, NY
Specialty
Allergy / Immunology

Data Provided by:
Juan L Sotomayor
(315) 701-9500
5229 Witz Drive
North Syracuse, NY
Specialty
Allergy / Immunology

Data Provided by:
Data Provided by:

Transplant for Metabolic Disorders

Provided By:

FRIDAY, Oct. 16 (HealthDay News) -- U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb.

The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

She and her team are studying the new procedure in a pilot trial open to pregnant women at risk for having children with fatal metabolic disorders, including Krabbe disease, metachromatic leukodystrophy, Pelizaeus-Maerzbacher disease, Tay-Sachs disease and Sandoff disease.

If untreated, these metabolic disorders can lead to bone, brain and central nervous system problems, and early death, the study authors noted in a Duke news release.

Donor cells used in the study will be made by the biopharmaceutical company Aldagen, Inc, which is a partner in the trial.

In many cases, cord-blood transplants after birth have proven successful in treating inherited metabolic disorders. Transplant timing is critical, Kurtzberg stressed.

"The idea is to give the baby cord-blood stem cells from a healthy donor that have the potential to provide healthy genes that can replace the ones that aren't working properly in the baby's own cells," Kurtzberg said in the news release.

In general, the earlier the transplant, the more likely it will work. That means that performing the transplant before the baby is born is ideal, she explained.

During the procedure, donor cells are injected directly into the fetus's abdomen at 12 to 14 weeks' pregnancy. At birth, the baby will be tested to see if the donor cells are present, and if they're fixing the malfunctioning genes. If not, the baby would be eligible for conventional cord-blood stem cell transplant within a few weeks.

More information

The Nemours Foundation has more about metabolism and metabolic disorders.

SOURCE: Duke Medicine, news release, Oct. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com